Skip to content

Bayer

Recent events

Recent events tied to this brand in public sources.

Back to profile95 entries · Page 4 of 5

  1. 2020

    Bayer announces acquisition of AskBio

    Bayer announced that it would acquire Asklepios BioPharmaceutical (AskBio), expanding its cell and gene therapy capabilities.

  2. 2020

    Bayer asks California Supreme Court to review Roundup verdict

    Bayer asked the California Supreme Court to review a decision affirming a $20.5 million award to groundskeeper Dewayne Johnson, who claimed Roundup caused his cancer. Bayer argued the ruling conflicted with federal law and settled legal principles; the request was an appeal, not a new court determination.

  3. 2020

    Bayer and Recursion enter strategic collaboration on fibrotic diseases

    Bayer and Recursion Pharmaceuticals entered a strategic collaboration to use Recursion's AI-guided drug discovery platform and Bayer's compound library and scientific expertise to discover and develop treatments for fibrotic diseases.

  4. 2020

    Bayer and Hua Medicine form a strategic partnership to develop dorzagliatin

    Bayer and Hua Medicine formed a strategic partnership to jointly develop the diabetes drug dorzagliatin. Hua Medicine will handle clinical development, registration, supply and distribution, while Bayer will provide marketing, promotion and medical education services in China.

  5. 2020

    FDA approves Lampit for pediatric Chagas disease treatment

    The U.S. Food and Drug Administration approved Lampit (nifurtimox) for treating Chagas disease in pediatric patients from birth to under 18 years old who weigh at least 2.5 kg. The article says Lampit is not approved in the U.S. for adults aged 18 or older.

  6. 2020

    California appeals court upholds Monsanto liability in Roundup cancer case

    A California appeals court denied Monsanto a new trial and affirmed its liability to Dewayne Johnson, while reducing the damages and conditioning the denial of a new trial on Johnson accepting the reduced amounts. The judges said Johnson presented substantial evidence that Roundup products caused his cancer.

  7. 2020

    California appeals court upholds Roundup verdict and reduces damages

    A California appeals court rejected Bayer’s bid to overturn a verdict for a school groundskeeper who claimed Roundup caused his cancer, while reducing the damages to US$20.5 million. The court said the plaintiff offered abundant evidence that glyphosate together with other ingredients in Roundup products caused his cancer.

  8. 2020

    California appeals court upholds Monsanto liability and reduces award

    The California Court of Appeal in San Francisco upheld the liability verdict against Monsanto in Dewayne Johnson's Roundup case and reduced his award from $78.5 million to $20.5 million. Bayer said it continued to believe the verdict and awards were inconsistent with the trial evidence and law.

  9. 2020

    Bayer teams up with pharmacy chains to create dermatology health centers

    Bayer upgraded its dual-brand strategy and teamed up with pharmacy chains to create dermatology health centers combining health education, medication consultation and purchasing experiences.

  10. 2020

    Bayer and Prospera partner on digital solutions for greenhouse growers

    Bayer and Prospera Technologies entered into a strategic partnership to develop digital solutions for vegetable greenhouse growers. The initial rollout and in-field exploration were planned to begin in Mexico in July 2020.

  11. 2020

    Bayer reaches Roundup settlement agreement

    Bayer agreed to a roughly $10.5 billion deal to settle tens of thousands of lawsuits brought by U.S. plaintiffs alleging that its Roundup herbicide causes cancer. The reported agreement included about $9.5 billion for claims represented by lawyers for roughly 95,000 plaintiffs and about $1.1 billion for a panel to evaluate whether the product causes cancer.

  12. 2020

    Bayer reaches settlements over Roundup, dicamba and PCB claims

    Bayer reached settlements resolving claims involving Roundup, dicamba-related crop damage and PCB pollution. The Roundup settlement addresses claims alleging the weed killer caused cancer; the source says the agreement includes no admission of liability. Bayer will pay farmers $400 million for dicamba crop-damage claims and roughly $650 million to resolve PCB waterway-pollution cases, with a separate $170 million agreement concerning PCB claims by three government plaintiffs.

  13. 2020

    Bayer announces settlements of Roundup, dicamba and PCB litigation

    Bayer announced agreements to settle Roundup cancer litigation, dicamba drift litigation and some PCB water litigation exposure in the United States. The article reports the settlement amounts and notes that some agreements remain subject to court approval.

  14. 2020

    Bayer and MassBio launch joint mentorship program

    Bayer and MassBio announced the launch of the Bayer-MassCONNECT Asia joint mentorship program for early-stage life-sciences entrepreneurs and researchers, particularly in China and Asia. The program connects participants with experts and resources in Massachusetts.

  15. 2020

    WaveForm Diabetes and Bayer enter commercial agreement for China glucose monitoring solutions

    WaveForm Diabetes announced a commercial agreement with Bayer to provide continuous glucose monitoring solutions in China. WaveForm will develop a 15-day-wear CGM, while Bayer will handle commercialization, distribution, sales, and customer support in mainland China.

  16. 2020

    Bayer Vietnam executive fined over internal document

    Vietnamese authorities fined Bayer Vietnam managing director Lynette Moey Yu Lin VND30 million for disseminating an internal document containing an image of China’s ‘nine-dash line,’ which authorities said wrongly showed Vietnam’s sovereignty.

  17. 2020

    D.C. sues Monsanto over PCB pollution allegations

    The District of Columbia sued Monsanto and affiliated companies, alleging that they knowingly manufactured, promoted and sold toxic chemicals that polluted local waterways. Bayer, which acquired Monsanto, denied that Monsanto used or dumped PCBs into the District’s waterways and said it would respond to the complaint.

  18. 2020

    Bayer partners with PHRI on COVID-19 clinical research

    Bayer's Canadian arm teamed up with the Population Health Research Institute to launch a clinical research programme seeking potential COVID-19 treatments. The programme includes two studies evaluating combination therapies, including Bayer's chloroquine and interferon beta-1b.

  19. 2020

    WuXi Biologics completed acquisition of Bayer manufacturing plant

    WuXi Biologics announced that it completed the acquisition of a drug product manufacturing plant in Leverkusen, Germany, from Bayer. WuXi Biologics took over plant operations and purchased the plant equipment.

  20. 2020

    Bayer launches Saudi recruitment campaign

    Bayer launched the digitally led #MoveForwardwithBayer campaign in Saudi Arabia to recruit local talent. The company said it aims to recruit more than 140 additional team members by 2021.